C07D 211/62
Attached in position 4
Official title: attached in position 4
C07D211/62 (Attached in position 4) appears on 1,011 US grants and 963 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,011
- Published applications
- 963
- Assignees
- 498
- Inventors
- 3,195
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 13 | 0 |
| 1978 | 14 | 0 |
| 1979 | 10 | 0 |
| 1980 | 19 | 0 |
| 1981 | 14 | 0 |
| 1982 | 9 | 0 |
| 1983 | 7 | 0 |
| 1984 | 8 | 0 |
| 1985 | 5 | 0 |
| 1986 | 4 | 0 |
| 1987 | 6 | 0 |
| 1988 | 9 | 0 |
| 1989 | 5 | 0 |
| 1990 | 4 | 0 |
| 1991 | 8 | 0 |
| 1992 | 10 | 0 |
| 1993 | 8 | 0 |
| 1994 | 11 | 0 |
| 1995 | 4 | 0 |
| 1996 | 20 | 0 |
| 1997 | 35 | 0 |
| 1998 | 23 | 0 |
| 1999 | 28 | 0 |
| 2000 | 29 | 0 |
| 2001 | 33 | 8 |
| 2002 | 40 | 41 |
| 2003 | 22 | 47 |
| 2004 | 28 | 71 |
| 2005 | 22 | 56 |
| 2006 | 28 | 71 |
| 2007 | 30 | 53 |
| 2008 | 28 | 38 |
| 2009 | 53 | 47 |
| 2010 | 36 | 38 |
| 2011 | 31 | 38 |
| 2012 | 23 | 23 |
| 2013 | 28 | 24 |
| 2014 | 29 | 40 |
| 2015 | 17 | 36 |
| 2016 | 29 | 39 |
| 2017 | 40 | 35 |
| 2018 | 38 | 36 |
| 2019 | 29 | 32 |
| 2020 | 21 | 29 |
| 2021 | 18 | 21 |
| 2022 | 20 | 30 |
| 2023 | 17 | 36 |
| 2024 | 14 | 28 |
| 2025 | 19 | 26 |
| 2026 | 9 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Modulators of programmed death-ligand-122 Sep 2026US 12,741,965 B2Southern Research Institute
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Amino lipid and preparation method and application thereof14 Jul 2026US 12,679,801 B2Shenzhen MagicRNA Biotechnology Co., Ltd.
- Luminally-acting N-(piperidin-4-yl)benzamide derivatives16 Jun 2026US 12,653,815 B2Takeda Pharmaceutical Company Limited
- Carboxylic acid containing indanyl compounds for the treatment of neurodegenerative diseases12 May 2026US 12,624,003 B2Celgene Corporation
- Crystal form of muscarine antagonist, method for preparing same, and use thereof24 Sep 2026US 2026/0285810 A1Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
- Long-chain alkenyloxy-substituted benzoyl derivative and oligonucleotide synthesis method using same17 Sep 2026US 2026/0274885 A1SPERA PHARMA, Inc.
- Lipid compounds, compositions, and uses thereof20 Aug 2026US 2026/0242346 A1Liberate Bio, Inc.
- Lipid compounds, compositions, and uses thereof13 Aug 2026US 2026/0234115 A1Liberate Bio, Inc.
- Compounds and methods for the treatment of ocular disorders13 Aug 2026US 2026/0234132 A1Azura Ophthalmics Ltd.
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Heterocyclo inhibitors of potassium channel function120US 7,005,436 B2Bristol-Myers Squibb Company · 2006
- Compounds and compositions for delivering active agents116US 5,773,647 AEmisphere Technologies, Inc. · 1998
- Arylsulfonamido-substituted hydroxamic acids110US 5,455,258 ACiba-Geigy Corporation · 1995
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994